Building effective prophylaxis of deep vein thrombosis in the outpatient setting

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 6 SUPPL. 2, 1999, Pages

  Agnelli, G ^a,b   Taliani, M R ^a   Verso, M ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Deep vein thrombosis; Low molecular weight heparins; Outpatient therapy; Prolonged prophylaxis; Prophylaxis for postoperative thromboembolism; Pulmonary embolism

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BLEEDING; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; HUMAN; LONG TERM CARE; LUNG EMBOLISM; OUTPATIENT CARE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM;

AMBULATORY CARE; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; HEPARIN; HUMANS; POSTOPERATIVE CARE; VENOUS THROMBOSIS;

EID: 0032860226     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Bergqvist D. Prolonged prophylaxis in postoperative medicine. Semin Thromb Hemost 1997; 23: 149-154.
2. Scurr JH. How long after surgery does the risk of thromboembolism persist? Acta Chir Scand 1990; 156 (suppl 556): 22-24.
3. Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge. Arch Surg 1992; 127: 310-313.
4. Paiement GD, Wessinger SJ, Harris WH. Survey of prophylaxis against venous thromboembolism in adults undergoing hip surgery. Clin Orthop 1987; 223: 188-193.
5. Sikorski JM, Hampson WG, Staddon GE. The natural history and aetiology of deep vein thrombosis after total hip replacement. J Bone Joint Surg Br 1981; 63: 171-177.
6. Kakkar VV, Fok PJ, Murray WJ, Paes T, Merenstein D, Dodds R, et al. Heparin and dihydroergotamine prophylaxis against thrombo-embolism after hip arthroplasty. J Bone Joint Surg 1985; 67: 538-542.
7. Swierstra BA, Stibbe J, Schouten HJ. Prevention of thrombosis after hip arthroplasty. A prospective study of preoperative oral anticoagulants. Acta Orthop Scand 1988; 59: 139-143.
8. Scurr JH, Coleridge-Smith P, Hasty J. Deep venous thrombosis: a continuing problem. BMJ 1988; 28: 297.
9. Johnson R, Green JR, Charnley J. Pulmonary embolism and its prophylaxis following Charnley total hip replacement. Clin Orthop 1977; 127: 123-132.
10. Coventry MB, Nolan DR, Beckenbaugh RD. 'Delayed' prophylactic anticoagulation: a study of results in 2012 total hip arthroplasties. J Bone Joint Surg Am 1973; 55: 1487-1492.
11. Bergqvist D. Postoperative Thromboembolism; Frequency, Etiology, Prophylaxis. Berlin: Springer Verlag, 1983.
12. Turpie AGG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315: 925-929.
13. Jørgensen LN, Wille-Jørgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993; 80: 689-704.
14. Sheppeard H, Henson J, Ward DJ, O'Connor BT. A clinicopathological study of fatal pulmonary embolism in a specialist orthopaedic hospital. Arch Orthop Trauma Surg 1981; 99: 65-71.
15. Nurmohamed M, Rosendaal F, Buller H, Dekker E, Hommes D, Vandenborucke J, Briet E. Low molecular weight heparin versus standard heparin in general and orthopedic surgery. A meta-analysis. Lancet 1992; 340: 152-156.
16. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Ann Surg 1988; 208: 227-240.
17. Imperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994; 272: 1780-1785.
18. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308: 235-246.
19. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318: 1162-1173.
20. Barnes RW, Collicott PE, Mozersky KJ, Summer DS, Strandness DE. Non-invasive quantification of maximum venous outflow in acute thrombophlebitis. Surgery 1972; 72: 971-979.
21. Dahl OE, Pedersen T, Kierulf P, Westwik A-B, Lund P, Arnesen H, et al. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res 1993; 70: 451-458.
22. Dahl OE, Aspelin T, Arnesen H, Seljeflot I, Kierulf P, Ruyter R, Lyberg T. Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res 1995; 4: 299-306.
23. MacNally MA, Molland RAB. Total hip replacement, lower limb blood flow and venous thrombogenesis. J Bone Joint Surg 1993; 75B: 640-644.
24. Dahl OE, Andreassen G, Aspelin T, Muller C, Mathiesen P, Nyhus S, et al. Prolonged thromboprophylaxis following hip replacement surgery - results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997; 77: 26-31.
25. Seagroatt V, Tan HS, Goldacre M, Bulstrode C, Nugent I, Gill L. Elective hip replacement: incidence, emergency readmission rate and postoperative mortality. BMJ 1991; 303: 1431-1435.
26. Nicolaides A, Arcelus J, Belcaro G, Bergqvist D, Borris LC, Buller HR, et al. Prevention of venous thromboembolism. European Consensus Statement. Int Angiol 1992; 11: 151-159.
27. Leizorovicz A, Haugh MC, Chapuis F-R, Samama M, Boisel J-P. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305: 913-920.
28. Planes A, Vochelle N, Maze F, Mansat C, Zucman J, Landais A, et al. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988; 60: 407-410.
29. Leyvraz PF, Backmann F, Hoek J, Buller H, Postel M, Samama M, Vandenbroak M. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ 1991; 303: 543-548.
30. Eriksson BI, Zachrisson BE, Teger-Nilsson AC, Risberg B. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement. Br J Surg 1988; 75: 1053-1057.
31. Zagrodnik J, Kaufner HK. Ambulante Thromboembolieprophylaxe in der Tramatologie durch Selbstinjektion von Heparin. Unfallchirurg 1990; 92: 331-333.
32. Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335: 696-700.
33. Dahl OE, Andreasson G, Müller C, Mathisen P, Nyhus S, Aspel T, et al. The effect of prolonged thromboprophylaxis with dalteparin on the frequency of deep vein thrombosis and pulmonary embolism 35 days after hip replacement surgery. Thromb Haemost 1995; 73: 1094 (Abstr)
34. Lassen MR, Berris LC, on behalf of the Danish Prolonged Prophylaxis Study Group. Prolonged thromboprophylaxis with low molecular weight heparin (Fragmin) after elective total hip arthroplasty - a placebo-controlled study. Thromb Haemost 1995; 73: 1104 (Abstr)
35. Planes AN, Vochelle N, Darmon J-Y, Fagola M, Bellaud M, Huet Y. Risk of deep venous thrombosis after hospital discharge in patients undergoing total hip replacement. Double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996; 348: 224-228.
36. Detournay B, Planes A, Vochelle N, Fagnani F. Cost effectiveness of a low-molecular-weight heparin in prolonged prophylaxis against deep vein thrombosis after total hip replacement. Pharmacoeconomics 1998; 13: 81-89.
37. Nicolaides AN, Bergqvist D, Hull R, Ackchurin RS, Allegra C, Arcelus J, et al. Consensus statement: prevention of venous thromboembolism. Int Angiol 1997; 16: 3-38.
38. Clagett GP, Anderson FA, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest 1998; 114 (suppl): 531S-560S.